Showing results (41-50 of 294) with videos related to
Sort By:
Pageof 30
Annals of Internal Medicine|May 1, 1982
Elevated levels of circulating platelet aggregates and beta-thromboglobulin in sclerodermaM B Kahaleh, I Osborn, E C LeroyThe Journal of Clinical Investigation|September 1, 1984
Effects of neutrophil elastase and other proteases on porcine aortic endothelial prostaglandin I2 production, adenine nucleotide release, and responses to vasoactive agentsE C LeRoy, A Ager, J L GordonInflammation|March 1, 1983
Neutrophil response to LIF: lack of glucocorticoid effect despite enhanced chemokinesisD P Lurie, F DeLustro, E C LeRoyCell|May 8, 1987
TGF-beta inhibition of endothelial cell proliferation: alteration of EGF binding and EGF-induced growth-regulatory (competence) gene expressionK Takehara, E C LeRoy, G R GrotendorstProceedings of the National Academy of Sciences of the United States of America|February 1, 1982
Replication and phenotypic expression of control and scleroderma human fibroblasts: responses to growth factorsE C LeRoy, S Mercurio, G K ShererOncogene|October 1, 1988
Elevated expression of c-myc proto-oncogene in scleroderma fibroblastsM Trojanowska, L T Wu, E C LeRoyThe Medical Clinics of North America|January 1, 1997
Scleroderma and related conditionsH Mitchell, M B Bolster, E C LeRoyRheumatology International|January 1, 1983
A fibroblast mitogen present in scleroderma but not control sera: inhibition by proteinase inhibitorsE C LeRoy, M B Kahaleh, S MercurioThe Journal of Experimental Medicine|October 1, 1982
Cross-reactivity of cell-mediated immunity between interstitial (type I) and basement membrane (type IV) collagensA M Mackel, F DeLustro, E C LeRoyJournal of Molecular Medicine (Berlin, Germany)|April 16, 1998
Pathogenesis of fibrosis: type 1 collagen and the skinM Trojanowska, E C LeRoy, B Eckes, et al.Pageof 30